The Japanese Journal of Dermatology
Online ISSN : 1346-8146
Print ISSN : 0021-499X
ISSN-L : 0021-499X
Search
Advanced search
OR
Browse
Search
Volume 130, Issue 13
Displaying 1-6 of 6 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Obituary
Seminar for Medical Education
Original Articles
  • Analysis of Student Reports on the Subject of Hansen's Disease in Human Rights Education at Wakayama Medical University
    Fukumi Furukawa
    2020 Volume 130 Issue 13 Pages 2689-2697
    Published: December 20, 2020
    Released on J-STAGE: December 20, 2020
    DOIhttps://doi.org/10.14924/dermatol.130.2689
    JOURNAL RESTRICTED ACCESS
    Show abstractHide abstract

    For 13 years from 2005, Hansen's disease was utilized as a theme for human rights education for medical students. The method was to conduct a core curriculum-based lecture and human rights lectures in the second year. The post-class report introduced a newspaper article reporting on the normalization of illegal abortion at several facilities, and the students were asked to discuss both on the lectures and this article.

    Analysis of these medical student reports confirmed that Hansen's disease is an extremely useful theme for human rights education and clinical ethics education. In short, the students were surprised to learn that changes in appearance (ugliness) in the history of Hansen's disease led to prejudice, long-standing segregation policies, and human rights abuses. They also discovered that physicians were involved in the mistreatment, and that medical progress was insufficiently shared not only with physicians but also patients and citizens. Our analysis of 1347 reports on Hansen's disease and newspaper articles on "abortion and human rights of the unborn child", suggest that continuous efforts of medical ethics education are essential.

    View full abstract
    Download PDF (677K)
Quick Reports
  • COVID-19 Pneumonia in a Psoriasis Patient during Secukinumab Treatment
    Masahiro Fukuda, Yoshinori Umezawa, Kenji Sawaki, Akihiko Asahina
    2020 Volume 130 Issue 13 Pages 2699-2703
    Published: December 20, 2020
    Released on J-STAGE: December 20, 2020
    DOIhttps://doi.org/10.14924/dermatol.130.2699
    JOURNAL RESTRICTED ACCESS
    Show abstractHide abstract

    A 58-year-old patient developed psoriasis when he was 53. He has COPD. He had smoked 20 cigarettes/day from the age of 20 to 52 and 10 electronic cigarettes/day (iQOS®) from the age of 53. He was administrated secukinumab (SEC) for his psoriasis, which was improved by the treatment; he was maintaining PASI clear. In March 2020, he developed COVID-19 pneumonia and was prescribed hydroxychloroquine 400 mg/day for COVID-19 pneumonia with discontinuation of SEC. The COVID-19 pneumonia was ameliorated. He has maintained his improved condition without SEC treatment for 3 month to date.

    View full abstract
    Download PDF (530K)
Case Reports
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top